Cargando…

Systemic complement profiling in multiple sclerosis as a biomarker of disease state

BACKGROUND: There is increasing evidence of significant and dynamic systemic activation and upregulation of complement in multiple sclerosis (MS), which may contribute to disease pathogenesis. OBJECTIVE: We aimed to investigate the pathological role of complement in MS and the potential role for com...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ingram, G, Hakobyan, S, Hirst, CL, Harris, CL, Loveless, S, Mitchell, JP, Pickersgill, TP, Robertson, NP, Morgan, BP
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2012
Materias:	Research Papers
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3697901/ https://www.ncbi.nlm.nih.gov/pubmed/22354735 http://dx.doi.org/10.1177/1352458512438238

Ejemplares similares

Complement activation in multiple sclerosis plaques: an immunohistochemical analysis
por: Ingram, Gillian, et al.
Publicado: (2014)

Seasonal variation in multiple sclerosis relapse
por: Harding, Katharine, et al.
Publicado: (2017)

Multiple sclerosis and COVID-19: Assessing risk perception, patient behaviors and access to disease-modifying therapies
por: Beesley, R., et al.
Publicado: (2022)

Complement is activated in progressive multiple sclerosis cortical grey matter lesions
por: Watkins, Lewis M., et al.
Publicado: (2016)

Advances in biomarker research in multiple sclerosis
por: Butterworth, Sara E., et al.
Publicado: (2016)

KIF5A and the contribution of susceptibility genotypes as a predictive biomarker for multiple sclerosis
por: Hares, Kelly, et al.
Publicado: (2021)

Cerebrospinal fluid extracellular vesicle enrichment for protein biomarker discovery in neurological disease; multiple sclerosis
por: Welton, Joanne L., et al.
Publicado: (2017)

CSF-resident CD4(+) T-cells display a distinct gene expression profile with relevance to immune surveillance and multiple sclerosis
por: Hrastelj, James, et al.
Publicado: (2021)

Biomarkers of multiple sclerosis: current findings
por: Harris, Violaine K, et al.
Publicado: (2017)

Impact of complement activation on clinical outcomes in multiple sclerosis
por: Keller, Christian W., et al.
Publicado: (2021)

The role of the complement system in Multiple Sclerosis: A review
por: Saez-Calveras, Nil, et al.
Publicado: (2022)

Unreliability of putative fMRI biomarkers during emotional face processing
por: Nord, C.L., et al.
Publicado: (2017)

An “Outside-In” and “Inside-Out” Consideration of Complement in the Multiple Sclerosis Brain: Lessons From Development and Neurodegenerative Diseases
por: Morgan, B. Paul, et al.
Publicado: (2021)

The association between neurodegeneration and local complement activation in the thalamus to progressive multiple sclerosis outcome
por: Cooze, Benjamin J., et al.
Publicado: (2022)

Biomarkers in Multiple Sclerosis
por: Martin, Roland, et al.
Publicado: (2006)

Biomarkers of Therapeutic Response in Multiple Sclerosis: Current Status
por: Harris, Violaine K., et al.
Publicado: (2014)

Exploring in vivo lesion myelination dynamics: Longitudinal Myelin Water Imaging in early Multiple Sclerosis
por: Kitzler, Hagen H., et al.
Publicado: (2022)

Coagulation/Complement Activation and Cerebral Hypoperfusion in Relapsing-Remitting Multiple Sclerosis
por: Koudriavtseva, Tatiana, et al.
Publicado: (2020)

Mechanical strain disrupts primary cilia structure and modulates hedgehog signalling in adult chondrocytes
por: Thompson, CL, et al.
Publicado: (2012)

Plasma protein profiling reveals candidate biomarkers for multiple sclerosis treatment
por: Bedri, Sahl Khalid, et al.
Publicado: (2019)

Physical activity as a risk factor for amyotrophic lateral sclerosis-findings from three large European cohorts
por: M, Hu, et al.
Publicado: (2020)

Molecular biomarkers in multiple sclerosis
por: Ziemssen, Tjalf, et al.
Publicado: (2019)

Digital Biomarkers in Multiple Sclerosis
por: Dillenseger, Anja, et al.
Publicado: (2021)

Protein biomarkers in multiple sclerosis
por: Kim, Jun-Soon
Publicado: (2023)

Innovative biomarkers to predict unfavourable outcomes after initiating multiple sclerosis treatment
por: Kreft, Karim L., et al.
Publicado: (2022)

Effects of freezer storage time on levels of complement biomarkers
por: Morgan, Angharad R., et al.
Publicado: (2017)

Proteomic Profiling in Multiple Sclerosis Clinical Courses Reveals Potential Biomarkers of Neurodegeneration
por: Liguori, Maria, et al.
Publicado: (2014)

Multiple Sclerosis Cerebrospinal Fluid Biomarkers
por: Giovannoni, Gavin
Publicado: (2006)

Biomarkers in Multiple Sclerosis: Role of Antibodies
por: Berger, Thomas, et al.
Publicado: (2006)

Chemokine Receptors as Biomarkers in Multiple Sclerosis
por: Fox, Robert J., et al.
Publicado: (2006)

Inflammasome Proteins As Biomarkers of Multiple Sclerosis
por: Keane, Robert W., et al.
Publicado: (2018)

Current and Future Biomarkers in Multiple Sclerosis
por: Yang, Jennifer, et al.
Publicado: (2022)

Alemtuzumab for Multiple Sclerosis
por: Willis, Mark D., et al.
Publicado: (2016)

Myelin-specific multiple sclerosis antibodies cause complement-dependent oligodendrocyte loss and demyelination
por: Liu, Yiting, et al.
Publicado: (2017)

Divergent complement system activation in two clinically distinct murine models of multiple sclerosis
por: Linzey, Michael, et al.
Publicado: (2022)

Multiple sclerosis plasma IgG aggregates induce complement-dependent neuronal apoptosis
por: Zhou, Wenbo, et al.
Publicado: (2023)

Complement Profiles in Patients with Amyotrophic Lateral Sclerosis: A Prospective Observational Cohort Study
por: Kjældgaard, Anne-Lene, et al.
Publicado: (2021)

Complement system biomarkers in first episode psychosis
por: Kopczynska, Maja, et al.
Publicado: (2019)

Analysis of complement biomarkers in systemic sclerosis indicates a distinct pattern in scleroderma renal crisis
por: Okrój, Marcin, et al.
Publicado: (2016)

Cytokine profiles of lupus patients with or without nephritis
por: Rovin, BH, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_scll99o7511h8bafi2dr1ejr78